Vitamins & Supplements · Digestive enzyme
Digestive enzyme supplements
Lactase, alpha-galactosidase, lipase and multi-enzyme blends · also called Digestive enzymes, enzyme supplements, enzimas digestivas
Digestive enzyme supplements are pills or drops that contain enzymes such as lactase, alpha-galactosidase, lipase or mixed blends. They are not the same as prescription pancreatic enzymes, which treat a diagnosed pancreas condition. Lactase may help some people with lactose intolerance; trials of other products are small and often by the maker. Greasy stools or weight loss need a medical check, not a supplement.
General information, not medical advice. Last substantive update · Not medically reviewed. A named clinician has not signed off on this page. How this page is made
About Digestive enzyme supplements
Digestive enzymes are made by the body. Supplements are different products sold for lactose, gas or general digestion. The evidence is limited and varies by enzyme and product.
What digestive enzyme supplements are
Enzymes are proteins that break food down. The pancreas makes the enzymes that digest fat, protein and starch (AGA, NIDDK). Supplements contain single enzymes, such as lactase for the milk sugar lactose, or blends of several. A 2016 review says enzymes can come from animals, plants or microbes.
Prescription pancreatic enzyme replacement therapy (PERT) is a medicine for people with exocrine pancreatic insufficiency (EPI). Over-the-counter enzyme supplements are a different group of products and the sources read do not show they do the same job.
Foods, lactose and what the body makes
No source read gives the enzyme content of foods, so none is stated. The body makes its own digestive enzymes. For lactose, the NHS lists milk, butter, cheese, cream, yoghurt and ice cream, and many processed foods such as cereals with chocolate, baked foods, sauces and protein shakes.
A 2010 systematic review found most adults with presumed lactose intolerance tolerate 12 to 15 g of lactose, about 1 cup of milk. That is a tolerance finding, not a recommendation.
Pancreatic insufficiency is a medical condition
NIDDK lists symptoms of EPI as bloating, cramps, loose greasy bad-smelling stools, excess gas and weight loss. Common causes include chronic and acute pancreatitis, cystic fibrosis and pancreatic cancer or surgery; less common causes include diabetes and untreated coeliac disease.
The AGA review says a response to a trial of pancreatic enzymes is unreliable for diagnosis and that fecal elastase is the usual first test. Once EPI is diagnosed, PERT is required. Feeling better on a supplement is not a diagnosis.
What the research shows
Lactase has agency support for lactose intolerance (NIDDK, NHS), though a 2010 systematic review found limits. Two small trials of different multi-enzyme blends in functional dyspepsia reported better scores. Alpha-galactosidase for gas gave mixed results. FODMAP enzymes and lipase have only early, very small, industry-linked or healthy-volunteer studies. Lactase for infant colic is inconclusive.
Results cannot be moved from one product to another: each trial tested a specific enzyme or blend.
Quality, source and labels
A 2026 laboratory study checked four bromelain raw materials and found only one matched its declared activity and quality; one active sample was papain. This is one enzyme, but it shows that labels can be wrong.
Reviewers note that over-the-counter enzyme use is rising and that manufacturers make many health claims (2014 Mayo Clinic review abstract).
When to see a clinician first
The NHS says to see a GP for bloating that is regular, that lasts 3 weeks, or that comes with weight loss or blood in the stool. Greasy stools and unexplained weight loss are listed by NIDDK as EPI symptoms. These can have many causes; ask a doctor, pharmacist or dietitian before using an enzyme product, and especially before changing a prescribed enzyme.
At a glance
Traditional uses history, not proof
- Enzymes are made by the body to digest food
- Sold over the counter for lactose in dairy, gas after beans and general indigestion
Studied for research
- Prescription pancreatic enzymes for a diagnosed condition, high certainty (a role, not a supplement trial)
- Lactose intolerance (lactase), low certainty
- Indigestion with multi-enzyme blends, low certainty
- Gas after beans, mixed evidence
- FODMAP-targeting enzymes and lipase before a fatty meal, very low certainty
- Infant colic and general digestion claims, insufficient evidence
Main compounds
- Lactase (beta-galactosidase)
- Alpha-galactosidase
- Lipase
- Fructanase
- Bromelain (protein enzyme from pineapple)
- Multi-enzyme blends
Common forms
- Tablets, capsules and chewables
- Drops added to milk or taken with food
- Blends of several enzymes
Research links: 2023 AGA expert review: exocrine pancreatic insufficiency · 2010 systematic review: managing lactose intolerance · 2023 trial: enzyme blend in functional dyspepsia (120 adults) · 2016 trial: alpha-galactosidase in IBS · NIDDK: treatment for lactose intolerance · Research Library · Genes & Biomarkers Library
What it is and its history
- Accepted scientific name
- Digestive enzyme supplements (a group of products: lactase, alpha-galactosidase, lipase, protease blends, multi-enzyme blends)
- Common names
- Digestive enzymes (English); Enzyme supplements (English); Enzimas digestivas (Spanish)
- Family or group
- Enzyme supplements. Enzymes are proteins that speed up the breakdown of food. The NIDDK and the 2016 review describe pancreatic enzymes, lactase (beta-galactosidase) and related products.
- Harvest and processing
- Per the 2016 review, enzymes can come from animal (pancreatic), plant or microbial sources. A 2023 trial used a blend made by fungal fermentation. Prescription pancreatic enzymes are all porcine-derived (AGA). Manufacturing details were not read.
- Look-alikes and adulterants
- Name: Prescription pancreatic enzyme replacement therapy (PERT); Note: A prescribed medicine for diagnosed pancreatic insufficiency. Not the same as over-the-counter supplements.; Name: Probiotics; Note: Live microbes, not enzymes. They have their own pages.; Name: Bromelain and papain; Note: Protein-digesting enzymes from pineapple and other plants, with their own page.; Name: Betaine HCl and stomach-acid products; Note: Not enzymes; they have their own page.
- Sustainability and conservation
- Not assessed.
What is inside, and how it may work
What it contains and how those compounds act in cells and animals. Laboratory and animal mechanisms are not proven effects in people.
Main compounds
| Compound | Family | Where it is concentrated | Activity studied | Level of evidence |
|---|---|---|---|---|
| Lactase (beta-galactosidase) | carbohydrate-splitting enzyme | Not read from a source. | Breaks down lactose, the sugar in milk (NIDDK). 19 11 | Human data |
| Alpha-galactosidase | carbohydrate-splitting enzyme | Not read from a source. | Breaks sugars with an alpha-galactosidic link found in beans and some vegetables (trial abstract). 3 4 | Human data |
| Lipase | fat-digesting enzyme | Not read from a source. | Splits dietary fat. Stomach lipases break down 10% to 20% of dietary triglycerides (trial abstract). 8 | Human data |
| Fructanase | carbohydrate-splitting enzyme (microbial) | Not read from a source. | Breaks fructans such as inulin into fructose in the lab (trial abstract). 9 | Human data |
| Bromelain | protein-digesting enzyme complex from pineapple (Ananas comosus) | Pineapple (per the quality study abstract) Not read from a source. | Protein-digesting enzyme complex; no human digestive trial was read. 1 | Lab |
| Multi-enzyme blends | mixed enzymes (for example amylase, protease and lipase) | Contents differ by product and were not compared. | Tested in small dyspepsia trials as two different products. 12 10 | Human data |
Mechanisms, receptors and pathways
| Target or pathway | Gene or receptor | What was found | Level |
|---|---|---|---|
| Digestion of fat, protein and carbohydrate in the gut | Not applicable | Digestive enzymes break proteins, carbohydrates and lipids into parts that can be absorbed (2016 review abstract). In EPI the pancreas does not deliver enough of them (AGA). 5 13 | Human data |
| Fermentation of undigested sugars in the bowel | Not applicable | The authors of the alpha-galactosidase and fructanase studies propose that breaking sugars down before the colon may cut gas from fermentation. In the fructanase trial breath hydrogen and methane did not change. 4 9 | Human data |
Absorption, metabolism and elimination
- Absorption
- Enzymes act in the gut and are not studied for absorption in the sources read.
- Metabolism
- Not researched.
- Elimination
- Not researched.
- Bioavailability
- The AGA review says non-enteric-coated prescription enzymes need acid reduction; the trial of lipase used an acid-resistant capsule. Over-the-counter product release was not compared.
Isolated compounds versus whole extracts
Foods and pills are different here. The body already makes digestive enzymes. Lactose-containing foods (milk, cheese, yoghurt, cream, ice cream, butter, and many processed foods) are listed by the NHS. No amounts of enzymes in foods were read. A 2010 review found most adults with presumed lactose intolerance tolerate 12 to 15 g of lactose, about 1 cup of milk, a fact about tolerance and not advice.
Nutritional composition
Enzymes are not a vitamin or mineral and have no recommended intake. No food amounts of digestive enzymes were found. The only food figure used is lactose: 12 to 15 g (about 1 cup of milk) was well tolerated by most adults in a 2010 systematic review.
1 high certainty1 mixed findings2 low certainty2 very low certainty3 not enough evidence
What was looked at
The 9 benefits and uses checked for Digestive enzyme supplements, each with how strong the evidence is. Tap one to open it.
- The body's own digestive enzymes and prescribed pancreatic enzymesHigh certainty
- Lactase for lactose intoleranceLow certainty
- Multi-enzyme blends for indigestion (functional dyspepsia)Low certainty
- General "better digestion" claims for healthy peopleNot enough evidence
- Gas after beans and similar foods (alpha-galactosidase)Mixed findings
- Enzymes aimed at FODMAP sugars (fructan-digesting enzymes and blends)Very low certainty
- Lipase before a fatty mealVery low certainty
- Lactase drops for infant colicNot enough evidence
- Animal, plant and microbial enzymes, and what is really in the productNot enough evidence
Lab markers tracked in the studies
Fecal elastase (stool test)Dyspepsia symptom scores (Nepean Dyspepsia Index and others)Gas passed after a meal (flatulence events per hour)Breath hydrogen and methane
What is Digestive enzyme supplements good for?
The main studied uses and how strong the human evidence is for each. Results apply only to the product tested.
Benefits, one by one
Each card is a research question, not a promise. Tap a goal to filter. Open a card to see the studies, doses and limits.
The body's own digestive enzymes and prescribed pancreatic enzymes
High certaintyThe pancreas makes the enzymes that digest fat, protein and starch. When it cannot make enough (exocrine pancreatic insufficiency, or EPI), doctors prescribe pancreatic enzyme replacement therapy (PERT). That prescription treatment is a different thing from over-the-counter enzyme pills.
4 studiesPrescription PERT (porcine-derived per the AGA). Over-the-counter sup…
Studies, doses and limits
What the trials found
The AGA expert review (2023) says that once EPI is diagnosed, treatment with PERT is required, and that untreated EPI leads to fat malabsorption and malnutrition. NIDDK says doctors typically prescribe PERT, taken during meals and snacks. NIDDK lists symptoms of EPI as bloating, cramps, loose greasy bad-smelling stools, excess gas and weight loss. A 2016 review calls animal-derived enzymes the established standard of care.
Results
PERT is an established treatment for a diagnosed condition. This page found no trial showing that over-the-counter enzyme supplements do the same job or help people whose pancreas works normally.
Effect sizes as reported
No effect sizes apply: this is a description of a diagnosed condition and its prescribed treatment, from guidance and review articles.
Why this rating
High that the pancreas makes digestive enzymes and that PERT is the standard treatment for diagnosed EPI (AGA expert review and NIDDK). This says nothing about over-the-counter products.
Form and dose studied
Prescription PERT (porcine-derived per the AGA). Over-the-counter supplements are different products; the AGA review does not cover them.
Who was studied
People with a diagnosed pancreatic condition such as chronic pancreatitis, cystic fibrosis or pancreatic surgery.
Limits
The AGA review is expert opinion without formal evidence ratings. It does not say over-the-counter enzymes can stand in for PERT.
Why researchers looked
People ask whether enzyme pills are the same as the medicine given for a failing pancreas.
Traditional use
Digestive enzymes are made by the body, so their normal job is well known. That is different from showing that extra enzyme pills help people who make enough.
Proposed mechanism Established physiology
Enzymes break food down into parts the gut can absorb. In EPI the pancreas does not send enough of them to the intestine, so fat, protein and nutrients are not fully digested (AGA).
A proposed mechanism does not show that the effect happens in people.
Do not replace or change a prescribed enzyme with a supplement without asking the prescriber.
Lactase for lactose intolerance
Low certaintyLactase tablets or drops contain the enzyme that breaks down lactose, the sugar in milk. NIDDK and the NHS say they may help some people with lactose intolerance. They do not make the body produce more lactase.
4 studiesLactase tablets or drops (a single enzyme, beta-galactosidase). Doses…
Studies, doses and limits
What the trials found
NIDDK (reviewed February 2018) says lactase products can help some people manage symptoms and that no treatment raises the lactase the small intestine makes in lactase nonpersistence. The NHS (July 2026) says a lactase supplement before lactose-containing food may reduce or prevent symptoms for some people. A 2010 systematic review found 36 randomised trials of lactose-intolerance strategies, 26 of them on lactase or lactose-hydrolysed or lactose-reduced milk or tolerable lactose amounts. It could not pool results and judged the evidence for the main comparison insufficient.
Results
Agencies describe lactase as possibly helpful for some people. The best systematic review found the trial evidence hard to pool and in part insufficient, and it is from 2010.
Effect sizes as reported
The 2010 review found moderate-quality evidence that 12 to 15 g of lactose (about 1 cup of milk) is well tolerated by most adults. It found insufficient evidence that very low lactose milk (0 to 2 g) beats milk with more than 12 g.
Why this rating
Low: agency pages say it may help some people, but the one systematic review found the evidence insufficient on the key comparison, searched only to 2009, and most trials studied lactose malabsorption rather than symptoms.
Form and dose studied
Lactase tablets or drops (a single enzyme, beta-galactosidase). Doses in trials varied and are not given here.
Who was studied
Adults and children with lactose intolerance or lactose malabsorption; trials mostly studied malabsorption.
Limits
Most trials were old, small and varied. Lactose intolerance can have other causes such as coeliac disease or bowel disease, which need their own care (NHS).
Why researchers looked
Lactose intolerance is common, and lactase is the one enzyme product with an agency description for a specific food problem.
Traditional use
Digestive enzymes are made by the body, so their normal job is well known. That is different from showing that extra enzyme pills help people who make enough.
Proposed mechanism Established physiology
Lactase splits lactose into sugars the gut can take up, so less lactose reaches the large bowel (NIDDK).
A proposed mechanism does not show that the effect happens in people.
NIDDK says to check with a doctor before using lactase products, since young children and pregnant or breastfeeding women may not be able to use them.
Multi-enzyme blends for indigestion (functional dyspepsia)
Low certaintyBlends of several enzymes are sold for general indigestion. Two small placebo-controlled trials in people with functional dyspepsia reported better symptom scores, but each tested one specific product and one was by the maker.
2 studiesTwo different multi-enzyme blends (fungal-fermented blend; a branded …
Studies, doses and limits
What the trials found
A 2023 trial of 120 adults aged 18 to 59 (an Italian group) gave a fungal-fermented blend or placebo for 2 months and found better quality-of-life, pain and sleep scores with the blend and no side effects reported. A 2018 trial of 40 patients gave a branded multi-enzyme product or placebo for 60 days and found better scores on five dyspepsia measures, with no product-related adverse events. The authors of the 2018 trial are founders or employees of the company that makes the product.
Results
Both trials reported improvement. They are small, short and product-specific, and one is industry-linked.
Effect sizes as reported
Improvements on questionnaire and pain scales (P between 0.0033 and 0.0401 in the 40-person trial). No effect sizes were given in the abstract of the 120-person trial.
Why this rating
Low: two small randomised placebo-controlled trials in different blends, one with a conflict of interest, short follow-up and symptoms measured by questionnaire. No systematic review was found.
Form and dose studied
Two different multi-enzyme blends (fungal-fermented blend; a branded multienzyme complex). Results cannot be applied to other blends.
Who was studied
Adults with functional dyspepsia (no clear cause after medical assessment).
Limits
Small trials, 2 months or less, different products. Functional dyspepsia needs a diagnosis by a clinician first.
Why researchers looked
Many people with unexplained upper-stomach discomfort try enzyme blends.
Traditional use
Digestive enzymes are made by the body, so their normal job is well known. That is different from showing that extra enzyme pills help people who make enough.
Proposed mechanism Hypothesis
The trial authors suggest that a weakness in digestive enzymes might play a part in dyspepsia. This is a hypothesis; it was not shown in the trials.
A proposed mechanism does not show that the effect happens in people.
No product-related side effects were reported in these small trials. That does not rule out rarer effects.
General "better digestion" claims for healthy people
Not enough evidenceMakers often sell enzymes for general digestion or gut health. No trial in healthy people with ordinary digestion was found that shows lasting benefit from taking enzymes every day.
2 studiesNot applicable.
Studies, doses and limits
What the trials found
A 2014 Mayo Clinic review says over-the-counter enzyme use is increasing in the United States and that manufacturers make numerous health benefit claims. A 2016 review says animal-derived enzymes are the established standard of care and that plant- and microbe-derived enzymes are still being studied. The abstract of the 2014 review does not give results, and the full text was not read.
Results
No benefit for general digestion was found in the sources read.
Effect sizes as reported
No effect sizes apply.
Why this rating
Insufficient: reviews describe rising use and many claims but the sources read show no trial of daily use in healthy people.
Who was studied
Healthy adults.
Limits
Only abstracts of the reviews were read.
Why researchers looked
Over-the-counter enzyme use is rising and many health claims are made.
Traditional use
Digestive enzymes are made by the body, so their normal job is well known. That is different from showing that extra enzyme pills help people who make enough.
Proposed mechanism Not established
Not established. The body already makes its own enzymes.
A proposed mechanism does not show that the effect happens in people.
Natural does not mean harmless; see the Safety tab.
Gas after beans and similar foods (alpha-galactosidase)
Mixed findingsAlpha-galactosidase is an enzyme that breaks down certain sugars in beans and vegetables before they ferment in the bowel. A small 1994 trial found fewer gas events but no change in bloating or pain. A 2016 trial in IBS found no evidence to support routine use.
3 studiesAlpha-galactosidase solution (1994) and an alpha-galactosidase produc…
Studies, doses and limits
What the trials found
In the 1994 crossover trial, 19 people ate a meatless chili with enzyme drops or placebo. Flatulence events per hour were lower with the enzyme over 6 hours (P = 0.016), but significant in only one hour when hours were compared one by one. Bloating and pain did not differ. In a 2016 trial of 125 adults with IBS and bloating or flatulence, the enzyme showed a trend to lower symptom scores, more people left the enzyme group (18 versus 7, P = 0.016), often because of abdominal pain and diarrhoea. NIDDK lists lactase products for lactose intolerance as an example of supplements doctors may recommend for gas.
Results
Mixed: one old small trial showed fewer gas events, and a larger IBS trial did not support routine use.
Effect sizes as reported
1994: flatulence events per hour F = 2.87, P = 0.016. 2016: withdrawals 18 versus 7, P = 0.016.
Why this rating
Mixed: a very small 1994 crossover trial in healthy people versus a larger 2016 IBS trial that found no supporting evidence and more withdrawals on the enzyme.
Form and dose studied
Alpha-galactosidase solution (1994) and an alpha-galactosidase product taken at meals (2016). Brands and amounts differ and are not compared.
Who was studied
Healthy adults on a test meal (1994) and adults with IBS (2016).
Limits
Tiny first trial, old; second trial found only a trend and drop-outs may explain later improvement (authors).
Why researchers looked
Beans and some vegetables cause gas in many people.
Traditional use
The enzyme is sold as drops or tablets taken with food.
Proposed mechanism Established physiology
Alpha-galactosidase splits sugars with an alpha-galactosidic link that human gut enzymes cannot break (stated in the 2016 trial abstract).
A proposed mechanism does not show that the effect happens in people.
More withdrawals with abdominal pain and diarrhoea were seen in the IBS trial, and the authors say irritation cannot be excluded.
Enzymes aimed at FODMAP sugars (fructan-digesting enzymes and blends)
Very low certaintyFODMAPs are fermentable sugars that can cause gas and bloating in some people. Two recent studies looked at enzymes made to break them down. One had no control group; the other tested one fructan-digesting enzyme in healthy people.
2 studiesOne FODMAP-targeting blend (survey) and one microbial fructanase caps…
Studies, doses and limits
What the trials found
In a 2026 uncontrolled survey study, people with IBS who bought a FODMAP-targeting enzyme blend online reported improvement after 4 weeks: 78.0% for bloating and flatulence and 65.3% for abdominal pain. There was no control group. In a 2026 randomised crossover trial of 30 healthy adults given 25 g inulin, the main overall symptom score did not differ (P = 0.13); abdominal pain, burping and fatigue were lower in the first hours, and bloating, pain and flatulence were lower at 8 to 24 hours. Breath hydrogen and methane did not differ. The fructanase trial was funded by the company that distributes the enzyme; some authors of the survey study work for the company behind the blend.
Results
Early and industry-linked. The only controlled trial missed its main outcome and was in healthy volunteers given a large fructan load.
Effect sizes as reported
Survey: 78.0% (95% CI 69.7 to 84.5) reported better bloating and flatulence. Trial: main score P = 0.13; several secondary scores P below 0.05.
Why this rating
Very low: one uncontrolled survey and one small crossover trial in healthy people that missed its main outcome, both with industry ties.
Form and dose studied
One FODMAP-targeting blend (survey) and one microbial fructanase capsule (trial). Results cannot be applied to other products.
Who was studied
People with IBS who bought the product (survey); healthy adults (trial).
Limits
No placebo in the survey; the trial tested one large inulin dose in healthy people and many secondary outcomes.
Why researchers looked
Many people with irritable bowel syndrome (IBS) react to FODMAPs.
Traditional use
Enzymes aimed at these sugars are a newer type of supplement.
Proposed mechanism Laboratory and human
Fructanase breaks fructans (such as inulin) into fructose in the lab; the 2026 trial suggests this may cut fermentation. The breath-gas tests did not show it.
A proposed mechanism does not show that the effect happens in people.
Not enough safety information was found. Symptoms that keep coming back need a clinician.
Lipase before a fatty meal
Very low certaintyIn a very small trial, an acid-resistant lipase capsule taken just before a fatty liquid meal lowered the feeling of stomach fullness in 16 healthy people. Bloating, nausea and stomach muscle activity did not change.
2 studiesOne acid-resistant lipase capsule.
Studies, doses and limits
What the trials found
The 2015 crossover trial gave 16 healthy volunteers an acid-resistant lipase capsule or placebo before a 355-calorie liquid meal that was 55% fat. Fullness was lower with lipase (p < 0.05) but other symptoms were not.
Results
A small signal for one symptom after one meal.
Effect sizes as reported
Fullness p < 0.05; other outcomes not significant.
Why this rating
Very low: 16 healthy volunteers, one liquid meal, 60 minutes of follow-up.
Form and dose studied
One acid-resistant lipase capsule.
Who was studied
Healthy volunteers.
Limits
Not tested in people with fat intolerance, pancreatic disease or in real meals.
Why researchers looked
Fatty meals make some people feel full and uncomfortable.
Traditional use
Lipase is the enzyme that digests fat.
Proposed mechanism Established physiology
Stomach lipase digests 10% to 20% of dietary fat in the stomach (trial abstract).
A proposed mechanism does not show that the effect happens in people.
Greasy stools or weight loss are not a reason to try lipase; they need assessment (NIDDK).
Lactase drops for infant colic
Not enough evidenceA 2024 systematic review of five trials in 391 young infants found the evidence for lactase drops in colic inconclusive. Pooling two trials showed no difference in crying time.
2 studiesOral lactase drops in infants under 6 months.
Studies, doses and limits
What the trials found
Three of five randomised trials reported shorter crying, one only in a compliant group. The pooled analysis of two trials found no difference in crying (mean difference -17.66 minutes a day, 95% CI -60.8 to 25.5) or fussing. Risk of bias was low in only one trial.
Results
Inconclusive; no clear benefit.
Effect sizes as reported
Crying MD -17.66 min/day (CI -60.8 to 25.5); fussing MD 2.75 min/day (CI -58.2 to 57.2).
Why this rating
Insufficient: five small trials with mostly high risk of bias and large differences between them (I2 68% to 80%).
Form and dose studied
Oral lactase drops in infants under 6 months.
Who was studied
Infants under 6 months with colic.
Limits
Short trials of about a week. The review is about colic, not lactose intolerance.
Why researchers looked
Parents of crying babies look for treatments.
Traditional use
Lactase drops are sometimes given to babies.
Proposed mechanism Hypothesis
The idea is that lactose may play a part in colic; this is not established.
A proposed mechanism does not show that the effect happens in people.
NIDDK says young children may not be able to use lactase products; check with a doctor first.
Animal, plant and microbial enzymes, and what is really in the product
Not enough evidenceEnzyme products come from animals (the pancreas), plants (such as pineapple bromelain) or microbes. A 2026 laboratory check of four bromelain samples found only one matched its label.
2 studiesNot compared.
Studies, doses and limits
What the trials found
A 2016 review says animal-derived enzymes are the established standard of care while plant- and microbe-derived enzymes are a growing field. The 2026 laboratory study found that only 1 of 4 bromelain raw materials met its declared activity and quality, two had no activity and one was papain, not bromelain.
Results
No trial compares sources head to head. Label accuracy is a real concern for at least one enzyme.
Effect sizes as reported
Bromelain: 1 of 4 samples met its declared values.
Why this rating
Insufficient for source comparison; the quality check covered only four raw materials of one enzyme.
Form and dose studied
Not compared.
Limits
Bromelain results do not necessarily apply to lactase or lipase products.
Why researchers looked
People want to know which source works best and whether labels can be trusted.
Traditional use
Pancreatic extract is the traditional source; plant and microbial sources are newer.
Proposed mechanism Not applicable
Not applicable; this is about product make-up.
A proposed mechanism does not show that the effect happens in people.
See the Safety tab on quality.
Connections to the rest of health
How Digestive enzyme supplements connects to the rest of our health knowledge graph. Every link says what kind of connection it is. A safety link (for example to the liver) is a warning, not a benefit. A study that merely mentions a topic never creates a benefit link.
Explore every connection: goals, body systems, organs, symptoms, genes
A. Wellness goals
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Digestive Support | High certainty | The body's own digestive enzymes and prescribed pancreatic enzymes: The pancreas makes the enzymes that digest fat, protein and starch. When it cannot make enough (exocrine pancreatic insufficiency, or EPI), doctors prescribe pancreatic enzyme replacement therapy (PERT). That prescription treatment is a different thing from over-the-counter enzyme pills. | 13 17 16 5 | |
| Digestive Support | Low certainty | Lactase for lactose intolerance: Lactase tablets or drops contain the enzyme that breaks down lactose, the sugar in milk. NIDDK and the NHS say they may help some people with lactose intolerance. They do not make the body produce more lactase. | 19 15 11 18 | |
| Digestive Support | Low certainty | Multi-enzyme blends for indigestion (functional dyspepsia): Blends of several enzymes are sold for general indigestion. Two small placebo-controlled trials in people with functional dyspepsia reported better symptom scores, but each tested one specific product and one was by the maker. Gas after beans and similar foods (alpha-galactosidase): Alpha-galactosidase is an enzyme that breaks down certain sugars in beans and vegetables before they ferment in the bowel. A small 1994 trial found fewer gas events but no change in bloating or pain. A 2016 trial in IBS found no evidence to support routine use. | 12 10 3 4 18 | |
| Digestive Support | Not enough evidence | General "better digestion" claims for healthy people: Makers often sell enzymes for general digestion or gut health. No trial in healthy people with ordinary digestion was found that shows lasting benefit from taking enzymes every day. | 2 5 | |
| Digestive Support | Very low certainty | Enzymes aimed at FODMAP sugars (fructan-digesting enzymes and blends): FODMAPs are fermentable sugars that can cause gas and bloating in some people. Two recent studies looked at enzymes made to break them down. One had no control group; the other tested one fructan-digesting enzyme in healthy people. | 6 9 | |
| Digestive Support | Very low certainty | Lipase before a fatty meal: In a very small trial, an acid-resistant lipase capsule taken just before a fatty liquid meal lowered the feeling of stomach fullness in 16 healthy people. Bloating, nausea and stomach muscle activity did not change. | 8 16 | |
| Digestive Support | Not enough evidence | Lactase drops for infant colic: A 2024 systematic review of five trials in 391 young infants found the evidence for lactase drops in colic inconclusive. Pooling two trials showed no difference in crying time. | 7 19 | |
| Digestive Support | Not enough evidence | Animal, plant and microbial enzymes, and what is really in the product: Enzyme products come from animals (the pancreas), plants (such as pineapple bromelain) or microbes. A 2026 laboratory check of four bromelain samples found only one matched its label. | 5 1 |
B. Body systems
E. Health conditions
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Exocrine pancreatic insufficiency | Contraindication | Documented risk | Prescribed enzymes treat the diagnosed condition; supplements should not replace them. Prescribed pancreatic enzymes treat the diagnosed condition; supplements should not replace them. Preparation or compound: Over-the-counter enzyme supplements |
13 17 |
| Lactose intolerance | Preliminary | Agencies say lactase may help some people; trial evidence is limited. Preparation or compound: Lactase tablets or drops |
19 15 11 | |
| Functional dyspepsia | Preliminary | Two small product-specific trials reported better symptom scores. Preparation or compound: Multi-enzyme blends |
12 10 |
I. Biomarkers
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Fecal elastase (stool test) | Biological association | High certainty | Measured in trials: low in exocrine pancreatic insufficiency. A lab change is not the same as a health benefit. | 13 |
| Dyspepsia symptom scores (Nepean Dyspepsia Index and others) | Biological association | Low certainty | Measured in trials: lower symptom scores with the blend. A lab change is not the same as a health benefit. | 12 10 |
| Gas passed after a meal (flatulence events per hour) | Biological association | Low certainty | Measured in trials: fewer events with the enzyme in one small trial. A lab change is not the same as a health benefit. | 3 |
| Breath hydrogen and methane | Biological association | Low certainty | Measured in trials: no difference in the fructanase trial. A lab change is not the same as a health benefit. | 9 |
K. Biological pathways
L. Active compounds
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Lactase (beta-galactosidase) | Biological association | Human | Breaks down lactose, the sugar in milk (NIDDK). | 19 11 |
| Alpha-galactosidase | Biological association | Human | Breaks sugars with an alpha-galactosidic link found in beans and some vegetables (trial abstract). | 3 4 |
| Lipase | Biological association | Human | Splits dietary fat. Stomach lipases break down 10% to 20% of dietary triglycerides (trial abstract). | 8 |
| Fructanase | Biological association | Human | Breaks fructans such as inulin into fructose in the lab (trial abstract). | 9 |
| Bromelain | Biological association | Lab | Protein-digesting enzyme complex; no human digestive trial was read. Preparation or compound: Pineapple (per the quality study abstract) |
1 |
| Multi-enzyme blends | Biological association | Human | Tested in small dyspepsia trials as two different products. | 12 10 |
Each connection is stored with the ingredient, the connected record, the kind of connection, the evidence status, the supporting studies, the preparation or compound involved, and a review date (last reviewed October 26, 2026).
Evidence at a glance: what the research found for 9 outcomes
Each outcome below is one thing researchers measured. Certainty is how far the evidence can be trusted, not how well it works. The full studies are on the next tab.
The evidence
The research centre for Digestive enzyme supplements. Every record here was checked against PubMed or the publisher's page; we never list a study we have not verified.
Evidence by outcome
Bars show how many studies we found for each outcome, not how well it works. People are added up across trials only (reviews are not added, to avoid double counting).
How we rate evidence
High certainty
Several well-run trials or reviews agree; further research is unlikely to change the picture much.
Moderate certainty
Good trials point the same way, but some doubt remains.
Low certainty
Small, short or inconsistent trials. The finding could change with better research.
Very low certainty
Very little or very weak human data. Treat as a possibility only.
Mixed findings
Trials or reviews disagree with each other.
Not enough evidence
Not enough human research to say either way.
Evidence against
Good research found no benefit, or found harm.
We take the reviewers' own risk-of-bias and GRADE statements where they exist, and otherwise judge from study size, design, consistency, directness and whether a product matches what is sold. Many publications do not make evidence high. Method note: We started from our existing summary, re-opened every source on it, read NIDDK and NHS pages, and re-read PubMed abstracts for reviews and trials. Only abstracts were read for studies.
Study library: every study we checked 19
| Study | Design | People | Product, dose, length | Result |
|---|---|---|---|---|
| Benetti 2026 A Multidisciplinary Analytical Strategy for the Authentication and Quality Assessment of Bromelain in Dietary Supplements. Int J Mol Sci · PMID 42123415 · DOI |
Laboratory analysis n/a (lab analysis) |
4 Four commercial bromelain raw-material samples (from pineapple, Ananas comosus) |
Bromelain samples (a protein-digesting enzyme complex) Raw material · vs Declared specification on each label |
Only one of the four samples met the declared activity and quality. Two had no enzyme activity. One had activity that came from papain, not bromelain. 1 of 4 samples met its declared values (Not applicable) Methods, limits and fundingOutcomes: Whether activity and quality matched what was declared Limitations: Four samples only; raw materials, not finished products; bromelain is not the same as the multi-enzyme products on this page. Funding and conflicts: The authors declare no conflicts of interest. Read: abstract |
| Edakkanambeth Varayil 2014 Over-the-counter enzyme supplements: what a clinician needs to know. Mayo Clin Proc · PMID 25103998 · DOI |
Narrative review |
Review for clinicians on over-the-counter enzyme products | Over-the-counter enzyme supplements Mixed |
Over-the-counter enzyme use is increasing in the United States. Manufacturers make numerous health claims, driving use for many conditions and symptoms. The review aims to help clinicians guide patients. No numbers in the abstract (Not applicable) Methods, limits and fundingOutcomes: Use, claims, evidence, risks and benefits Limitations: Only the abstract was read, so the review's detailed findings are not reported here. Funding and conflicts: Not stated in the abstract. Read: abstract |
| Ganiats 1994 Does Beano prevent gas? A double-blind crossover study of oral alpha-galactosidase to treat dietary oligosaccharide intolerance. J Fam Pract · PMID 7964541 |
Randomised crossover trial |
19 19 people given a meatless chili test meal |
Alpha-galactosidase solution (an over-the-counter product, Beano) Oral drops Eight drops before the test meal (studied in the trial) Two test meals one week apart · vs Placebo drops |
Flatulence events per hour were significantly lower with the enzyme than placebo over 6 hours. The difference was significant only in the 5th hour when hours were compared one by one. No differences in bloating or pain. Flatulence events: F = 2.87, P = 0.016; 5th hour t = 2.19, P = 0.04 (Not given in the abstract) Methods, limits and fundingOutcomes: Flatulence events per hour, bloating and pain for 6 hours after the meal Limitations: Very small, single product, one test meal, 1994 trial. Funding not stated in the abstract. Funding and conflicts: Funding is not stated in the abstract. Read: abstract |
| Hillila 2016 Does oral alpha-galactosidase relieve irritable bowel symptoms? Scand J Gastroenterol · PMID 26133538 · DOI |
Randomised controlled trial |
125 125 adults with irritable bowel syndrome (IBS) and bloating or flatulence |
Alpha-galactosidase (AG) Taken at meals 12 weeks, with follow-up to week 16 · vs Placebo |
AG showed a trend toward a larger fall in symptom score and a higher responder rate at week 16. No difference in quality of life. More people left the AG group (18 versus 7, p = 0.016), more often citing abdominal pain and diarrhoea. The authors found no evidence to support routine use in IBS. Withdrawals 18 (AG) versus 7 (placebo), p = 0.016 (Not given in the abstract) Methods, limits and fundingOutcomes: IBS Symptom Severity Score, quality of life, responder rate, withdrawals Limitations: The score difference was a trend, not clearly significant. Authors say the later benefit could be due to non-responders dropping out. Funding not stated in the abstract. Funding and conflicts: Funding is not stated in the abstract. Read: abstract |
| Ianiro 2016 Digestive Enzyme Supplementation in Gastrointestinal Diseases. Curr Drug Metab · PMID 26806042 · DOI |
Narrative review |
Non-systematic review of enzyme supplementation in digestive disorders | Pancreatic enzymes, lactase (beta-galactosidase), conjugated bile acids Mixed |
Animal-derived enzymes are the established standard of care. Plant-based and microbe-derived enzymes are a growing area of study. Combinations of enzymes might become an option in future. No numbers in the abstract (Not applicable) Methods, limits and fundingOutcomes: Overview of enzyme use in digestive disease Limitations: A non-systematic review, so studies may have been missed. Read from the abstract only. Funding and conflicts: The authors state no conflict of interest. Read: abstract |
| Kaye 2026 FODMAP-Targeting Digestive Enzyme Blend for Management of Gastrointestinal Symptoms: A "Real-World" Pre-Post Intervention Cohort Study. Gastro Hep Adv · PMID 41908325 · DOI |
Uncontrolled before after survey |
People with irritable bowel syndrome who bought a FODMAP-targeting enzyme blend online and completed anonymous surveys | FODMAP-hydrolyzing digestive enzyme blend (one product) Oral blend 4 weeks |
After 4 weeks 78.0% reported better bloating and flatulence, 65.3% better abdominal pain; overall IBS symptom severity improved (P < .01). 78.0% (bloating and flatulence); 65.3% (abdominal pain) reported improvement (78.0% (95% CI 69.7 to 84.5); 65.3% (95% CI 56.3 to 73.2)) Methods, limits and fundingOutcomes: Self-reported IBS symptom severity, bloating, flatulence, pain, diarrhoea, constipation, quality of life Limitations: No control group or placebo, self-selected buyers, self-reported surveys; improvement cannot be attributed to the enzymes. Some authors are affiliated with Kiwi Biosciences. Funding and conflicts: Authors include employees of Kiwi Biosciences (listed in the author affiliations); funding is not stated in the abstract. Read: abstract |
| Kozlowska-Jalowska 2024 Effect of lactase supplementation on infant colic: Systematic review of randomized controlled trials. J Pediatr Gastroenterol Nutr · PMID 38426798 · DOI |
Systematic review meta analysis |
391 Five randomised trials in 391 infants under 6 months old with colic |
Oral lactase drops Drops 1 week in the pooled trials · vs Placebo or no treatment |
Three trials reported shorter crying, one only in a compliant subgroup. Pooling two trials found no difference in crying (mean difference -17.66 min a day) or fussing time (2.75 min a day). Overall evidence was inconclusive. Crying MD -17.66 min/day; fussing MD 2.75 min/day (both not significant) (Crying -60.8 to 25.5, I2 68%; fussing -58.2 to 57.2, I2 80%) Methods, limits and fundingOutcomes: Crying and fussing time per day Limitations: Risk of bias low in only one of five trials, high in three. Pooled data are from only two trials with large differences between them. Funding and conflicts: Not stated in the abstract. Read: abstract |
| Levine 2015 Lipase Supplementation before a High-Fat Meal Reduces Perceptions of Fullness in Healthy Subjects. Gut Liver · PMID 25287168 · DOI |
Randomised crossover trial |
16 16 healthy volunteers given a 355-calorie liquid meal that was 55% fat |
Acid-resistant lipase capsule Capsule 280 mg once before the meal (studied in the trial) One meal, symptoms rated for 60 minutes · vs Placebo capsule |
Fullness was lower with lipase than placebo (p < 0.05). No effect on bloating, nausea or stomach electrical activity. Fullness p < 0.05 (Not given in the abstract) Methods, limits and fundingOutcomes: Stomach fullness, bloating, nausea, stomach muscle electrical activity Limitations: Small, healthy people, one fatty liquid meal, 60 minutes. Funding not stated in the abstract. Funding and conflicts: Funding is not stated in the abstract. Read: abstract |
| Mah 2026 Oral Fructanase Administration Reduces Gastrointestinal Symptom Severity after Acute Inulin Challenge in Healthy Adults. J Nutr · PMID 42580594 · DOI |
Randomised crossover trial |
30 30 healthy adults (mean age 38.6) given a large inulin (fructan) challenge |
Microbial fructanase capsule (one ingredient) Capsule Single test meal with symptom tracking for 24 h · vs Placebo maltodextrin capsule |
The main 0 to 8 h overall symptom score did not differ significantly (P = 0.13). Abdominal pain (P = 0.044), fatigue (P < 0.001) and burping (P = 0.040) were lower at 0 to 8 h. At 8 to 24 h overall symptoms, bloating, pain and flatulence were lower. Breath hydrogen and methane did not differ. Main overall score P = 0.13 (not significant); several secondary scores P < 0.05 (P values only in the abstract) Methods, limits and fundingOutcomes: Gut symptom scores 0 to 8 h and 8 to 24 h, breath hydrogen and methane Limitations: Healthy volunteers given a large fructan load, not people with gut disease. Main outcome not significant. Many secondary outcomes tested. Funding and conflicts: Funded by BIO-CAT, Inc., which distributes the fructanase tested; two authors were its employees; trial registered NCT06628869. Registration: NCT06628869 Read: abstract |
| Majeed 2018 Evaluation of the Safety and Efficacy of a Multienzyme Complex in Patients with Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study. J Med Food · PMID 30156436 · DOI |
Randomised controlled trial |
40 40 patients with functional dyspepsia |
DigeZyme multienzyme complex (one branded product) Oral 50 mg three times a day (studied in the trial) 60 days · vs Placebo |
All dyspepsia scores improved more than with placebo (P between .0401 and .0033). No product-related adverse events and no significant changes in blood tests or vital signs. P = .0401 to .0033 across scores (Not given in the abstract) Methods, limits and fundingOutcomes: Five dyspepsia symptom scores; adverse events; blood tests Limitations: Only 40 people (20 per group), one branded product, 60 days. Funding and conflicts: Conflict of interest: the authors are founders or employees of the companies that make and market the product tested. Read: abstract |
| Shaukat 2010 Systematic review: effective management strategies for lactose intolerance. Ann Intern Med · PMID 20404262 · DOI |
Systematic review |
36 randomised trials in people with lactose intolerance or lactose malabsorption (to November 2009); 26 on lactase or lactose-hydrolysed milk, lactose-reduced milk or tolerable lactose amounts | Lactase supplements and lactose-hydrolysed milk (and probiotics, colonic adaptation) Mixed Not pooled Not pooled · vs Various |
Moderate-quality evidence that 12 to 15 g of lactose (about 1 cup of milk) is well tolerated by most adults. Evidence was insufficient that lactose-reduced milk (0 to 2 g lactose) beats milk with more than 12 g lactose. Evidence for probiotics, colonic adaptation and other agents was insufficient. No pooled effect sizes (results could not be pooled) (Not applicable) Methods, limits and fundingOutcomes: Symptoms of lactose intolerance; lactose amounts tolerated Limitations: Most trials studied lactose malabsorption rather than lactose intolerance; entry criteria, outcomes and agents varied too much to pool. Searched to 2009. Funding and conflicts: Supported by US NIH extramural funding (research support listed on PubMed); no industry funding stated in the abstract. Read: abstract |
| Ullah 2023 Efficacy of digestive enzyme supplementation in functional dyspepsia: A monocentric, randomized, double-blind, placebo-controlled, clinical trial. Biomed Pharmacother · PMID 37976892 · DOI |
Randomised controlled trial |
120 120 adults aged 18 to 59 with functional dyspepsia |
Multi-enzyme blend made by fungal fermentation (one product) Capsule 2 capsules a day, 200 mg of blend each (studied in the trial) 2 months · vs Placebo |
Quality-of-life, pain and sleep scores improved more with the blend than with placebo, with no side effects reported. Improvements in NDI-SF, VAS and PSQI scores (numbers not in the abstract) (Not given in the abstract) Methods, limits and fundingOutcomes: Nepean Dyspepsia Index (quality of life), pain scale, sleep quality Limitations: One centre, one product, 2 months. Results cannot be applied to other blends. Funding and conflicts: The authors declare no competing financial interests. Read: abstract |
| Whitcomb 2023 AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert Review. Gastroenterology · PMID 37737818 · DOI |
Expert review guidance |
Expert review of exocrine pancreatic insufficiency (EPI) for gastroenterologists | Prescription pancreatic enzyme replacement therapy (PERT), porcine-derived Amounts in the guidance are for prescribed PERT and are not given here |
Once EPI is diagnosed, treatment with pancreatic enzyme replacement therapy is required. A response to a trial of pancreatic enzymes is unreliable for diagnosing EPI. Fecal elastase below 100 micrograms per gram of stool is good evidence of EPI. EPI features include steatorrhea (fatty stools), weight loss, bloating and excessive flatulence. Non-enteric-coated PERT needs an acid-reducing medicine. PERT products are all porcine-derived. No effect sizes: best-practice advice statements (Not applicable) Methods, limits and fundingOutcomes: Who should be tested for EPI, how it is diagnosed, how it is treated Limitations: Expert opinion and literature review; no systematic review, so no formal ratings of evidence quality (stated in the abstract). Covers prescription enzymes, not over-the-counter supplements. Funding and conflicts: Not stated in the abstract. Read: abstract |
| s-nhs-bloating NHS: Bloating (page last reviewed 21 January 2026) · Source |
Health agency page n/a |
Methods, limits and fundingRead: full-text | ||
| s-nhs-lactose NHS: Lactose intolerance (page last reviewed 8 July 2026) · Source |
Health agency page n/a |
Methods, limits and fundingRead: full-text | ||
| s-niddk-epi-symptoms NIDDK: Symptoms & Causes for Exocrine Pancreatic Insufficiency (last reviewed January 2023) · Source |
Health agency page n/a |
Methods, limits and fundingRead: full-text | ||
| s-niddk-epi-treatment NIDDK: Treatment for Exocrine Pancreatic Insufficiency (last reviewed January 2023) · Source |
Health agency page n/a |
Methods, limits and fundingRead: full-text | ||
| s-niddk-gas NIDDK: Treatment for Gas in the Digestive Tract (last reviewed June 2021) · Source |
Health agency page n/a |
Methods, limits and fundingRead: full-text | ||
| s-niddk-lactose NIDDK: Treatment for Lactose Intolerance (last reviewed February 2018) · Source |
Health agency page n/a |
Methods, limits and fundingRead: full-text |
What we do not know yet
- No trial was read comparing over-the-counter enzymes with prescribed pancreatic enzymes.
- No long-term safety data beyond 2 months were read.
- No source was read on allergy to enzyme supplements or on medicine interactions.
- Which enzyme source (animal, plant, microbe) works best was not shown.
- How supplements are regulated (FDA, EU) was not researched.
- Foods that contain enzymes were not researched.
How new research is added
New studies are found by a saved PubMed search and placed in a review queue before the page changes.
Lab markers
What changed in blood or saliva tests during trials. A changed number is not the same as feeling or being healthier, and we give no "normal ranges".
Other 4
Fecal elastase (stool test)
Low in exocrine pancreatic insufficiency in trials
A stool test that measures an enzyme made by the pancreas. Low levels suggest the pancreas is not delivering enough enzymes.
High certaintyResults and what it means
Why it was measured
Doctors use it to check whether symptoms such as greasy stools and weight loss come from pancreatic insufficiency.
Statistical vs. clinical meaning
It is a way to diagnose EPI. A response to enzyme pills is not a reliable way to diagnose it.
Safety implication
Symptoms that suggest EPI need a medical assessment, not self-treatment with supplements.
| Study | Result | People | Product |
|---|---|---|---|
| 13 | A level below 100 micrograms per gram of stool provides good evidence of EPI; 100 to 200 is indeterminate. It can be done while taking PERT. | Adults with suspected EPI (expert guidance) | Not an enzyme-supplement outcome; a diagnostic test |
Dyspepsia symptom scores (Nepean Dyspepsia Index and others)
Lower symptom scores with the blend in trials
Questionnaires and pain scales that people fill in to rate indigestion symptoms and how much they affect life.
Low certaintyResults and what it means
Why it was measured
To see whether an enzyme blend changes how people with functional dyspepsia feel.
Statistical vs. clinical meaning
Symptom questionnaires can be influenced by expectation. Both trials were small and product-specific.
Safety implication
No product-related side effects were reported in these trials.
| Study | Result | People | Product |
|---|---|---|---|
| 12 | Better Nepean Dyspepsia Index, pain scale and sleep scores than placebo (numbers not in the abstract) | 120 adults with functional dyspepsia | Fungal-fermented multi-enzyme blend for 2 months |
| 10 | All five dyspepsia scores improved more than placebo, P from .0401 to .0033 | 40 patients with functional dyspepsia | Branded multienzyme complex for 60 days |
Gas passed after a meal (flatulence events per hour)
Fewer events with the enzyme in one small trial in trials
How many times a person passes gas in the hours after a test meal, counted from a diary.
Low certaintyResults and what it means
Why it was measured
To see whether alpha-galactosidase drops reduce gas after a bean-rich meal.
Statistical vs. clinical meaning
A small old trial; bloating and pain did not change.
Safety implication
None reported in the abstract.
| Study | Result | People | Product |
|---|---|---|---|
| 3 | Fewer events per hour with the enzyme than placebo over 6 hours (F = 2.87, P = .016); significant in the 5th hour only when hours were compared one by one | 19 people given a meatless chili | Alpha-galactosidase drops versus placebo |
Breath hydrogen and methane
No difference in the fructanase trial in trials
Gases made by gut bacteria when they ferment sugars, measured in the breath.
Low certaintyResults and what it means
Why it was measured
To see whether an enzyme reduces fermentation in the bowel.
Statistical vs. clinical meaning
Symptoms improved in some scores but the breath gases did not change, so how the enzyme works here is not shown.
Safety implication
None reported in the abstract.
| Study | Result | People | Product |
|---|---|---|---|
| 9 | Breath hydrogen and methane did not differ between fructanase and placebo | 30 healthy adults after a 25 g inulin challenge | Microbial fructanase capsule versus placebo |
Safety
What studies and official sources say about side effects, medicines and who should check first. Each point shows what kind of evidence it comes from.
Main points to know 4
- Do not swap prescribed pancreatic enzymes for a supplement. If a doctor has diagnosed exocrine pancreatic insufficiency, the AGA says pancreatic enzyme replacement therapy is required, and NIDDK says doctors typically prescribe it. Over-the-counter enzyme products are different and were not shown to do the same job. Ask the prescriber or a pharmacist before adding or changing anything. Authoritative guidance 13 17
- Some symptoms need a check-up, not a supplement. Loose greasy bad-smelling stools, weight loss, ongoing bloating, or blood in the stool can signal pancreatic insufficiency, coeliac disease or other illness. The AGA says a response to enzymes cannot reliably diagnose EPI, so feeling better on a product does not tell you why you had symptoms. The NHS says to see a GP for bloating that is regular, lasts 3 weeks, or comes with weight loss or blood in the stool. Authoritative guidance 13 16 14 15
- What is in the bottle may not match the label. A 2026 laboratory study of four commercial bromelain raw materials found only one matched its declared activity and quality; two had no activity and one was papain instead of bromelain. This is one enzyme and four samples, so it does not describe all enzyme products. Laboratory analysis 1
- Young children, pregnancy and breastfeeding. NIDDK says some people, such as young children and pregnant or breastfeeding women, may not be able to use lactase products and should check with a doctor first. No safety data for other enzyme products in these groups were found. Authoritative guidance 19
Side effects 3
| Effect | How often | Severity and recovery | Evidence |
|---|---|---|---|
| Abdominal pain and diarrhoea (alpha-galactosidase in IBS) The authors say a coincidence is possible but irritation of the gut cannot be excluded. | In a 125-person IBS trial, 18 people left the alpha-galactosidase group versus 7 in the placebo group (p = 0.016), more often citing abdominal pain and diarrhoea. | Not stated in the abstract Not stated | Randomised controlled trial 4 |
| No product-related side effects reported in two small dyspepsia trials Small, short trials, one by the product maker. They cannot show rare or long-term harm. | A 120-person trial reported no side effects, and a 40-person trial reported no product-related adverse events and no important blood-test changes (60 days). | Not applicable Not applicable | Randomised controlled trial 12 10 |
| Allergic reactions to enzymes Enzymes are proteins and some come from pineapple, fungi or pig pancreas. Whether any cause allergy was not researched. See the urgent signs for serious allergic reactions generally. | Proper evidence not found in the sources read. | Unknown Unknown | Not researched |
Liver
No liver injury from digestive enzyme supplements was found in the sources read. A liver-safety reference (LiverTox) was not opened for this page.
How often. No frequency was found.
Monitoring. No agency monitoring advice was found.
This is a safety connection. It is not evidence that Digestive enzyme supplements supports liver health.
Medicines and supplements 4
| With | Why it matters | Importance | Evidence | What to do |
|---|---|---|---|---|
| Prescribed pancreatic enzyme replacement therapy (PERT) prescription | Both supply digestive enzymes, so adding a supplement could overlap with or confuse a prescribed plan. No interaction study was read. | NIDDK says to follow the doctor's instructions for PERT and to talk with a doctor before using dietary supplements. | Authoritative guidance Not enough evidence 17 13 | Tell the prescriber or a pharmacist about any enzyme product. |
| Acid-reducing medicines (proton pump inhibitors, H2 blockers) prescription | The AGA review says non-enteric-coated prescription pancreatic enzymes need an acid-reducing medicine to work, because stomach acid can inactivate enzymes. This statement is about PERT, not over-the-counter products. | Relevant mainly to people on prescribed PERT. | Expert review Low certainty 13 | Ask the prescriber or pharmacist about timing and acid medicines. |
| Blood thinners and diabetes medicines prescription | Not researched. | No source on interactions between over-the-counter enzymes and these medicines was read. | Not researched Not enough evidence | Ask a pharmacist before combining any supplement with medicines. |
| Probiotics, fibre and other gut supplements supplement | Not researched. | No source on combining enzymes with other gut supplements was read. | Not researched Not enough evidence | Ask a pharmacist. |
Who should check first 4
| Situation | Advice | Evidence |
|---|---|---|
| Diagnosed pancreatic insufficiency or pancreas disease | Do not replace or change prescribed enzymes with a supplement. Talk with the prescriber or pharmacist first. | Authoritative guidance 13 17 |
| Young children, pregnancy and breastfeeding (lactase products) | NIDDK says check with a doctor before using lactase products. No safety information was found for other enzyme supplements in these groups. | Authoritative guidance 19 |
| Unexplained weight loss, greasy stools, blood in stool, or bloating that lasts weeks | These need a medical assessment. See a GP (NHS) rather than self-treating with enzymes. | Authoritative guidance 14 15 16 |
| Kidney disease, liver disease or before surgery | No source on enzyme supplements in these situations was read. Tell your clinician or pharmacist about any enzyme product. | Not researched |
Overdose, product quality and regulators
Summary. No toxicity data for over-the-counter digestive enzyme supplements as a group were found in the sources read.
Animal. Not reviewed.
Overdose response. Not researched.
Genotoxicity. Not researched.
Only one quality study was read: a 2026 laboratory check of four bromelain raw materials.
Label accuracy (bromelain). Only one of four commercial bromelain raw materials met its declared activity and quality; two had no enzyme activity and one was papain, not bromelain. 1
| Body | Action | Date |
|---|---|---|
| NIDDK (US National Institutes of Health) (United States) | Says lactase tablets or drops can help some people manage lactose intolerance symptoms; no treatment raises the lactase the small intestine makes in lactase nonpersistence; check with a doctor before use, since young children and pregnant or breastfeeding women may not be able to use them. source | 2018-02 |
| NIDDK (US National Institutes of Health) (United States) | Says doctors typically prescribe pancreatic enzyme replacement therapy for EPI, taken during meals and snacks, and to talk with a doctor before using dietary supplements. source | 2023-01 |
| American Gastroenterological Association (AGA) (United States) | Clinical Practice Update expert review: once EPI is diagnosed, treatment with pancreatic enzyme replacement therapy is required; a response to enzymes is unreliable for diagnosis; prescription PERT is porcine-derived. source | 2023-11 |
| NHS (UK) (United Kingdom) | Says a lactase supplement before lactose-containing food may reduce or prevent symptoms for some people, and to see a GP if symptoms keep coming back or come with blood in the stool or weight loss. source | 2026-07-08 |
When to get medical help
- Vomiting blood or vomit that looks like coffee grounds, or a sudden severe stomach ache with a swollen stomach: call emergency services (NHS bloating page).
- Bloating with vomiting, a fever, a lump in the tummy, or being unable to pass wind or stool: get urgent medical help (NHS).
- Swelling of the lips, mouth, throat or tongue, fast or hard breathing, or fainting after any food or product: call emergency services (NHS lists these as signs of a serious allergic reaction).
- Unplanned weight loss, greasy bad-smelling stools, or blood in the stool: see a doctor soon.
Stop using the product and contact a clinician or emergency service. In the US, Poison Control is 1-800-222-1222.
General information only, not medical advice. Ask a clinician or pharmacist before use, especially with medicines, in pregnancy or with a health condition. See the Natural Remedy Safety guide.
Frequently asked questions
What are digestive enzyme supplements?
Are they the same as prescription pancreatic enzymes?
Does lactase help with lactose intolerance?
Do enzyme blends help indigestion?
Does alpha-galactosidase stop gas from beans?
Do FODMAP enzymes work?
Can enzymes diagnose or treat pancreatic problems?
Do enzymes help healthy people digest better?
Are digestive enzymes safe?
Can I use them in pregnancy or for children?
NIDDK says young children and pregnant or breastfeeding women may not be able to use lactase products and should check with a doctor first. No safety data for other enzymes in these groups were found.
Do enzyme supplements interact with medicines?
Are labels reliable?
A 2026 lab study found only 1 of 4 bromelain raw materials matched its declared activity and quality. That is one enzyme, but it shows labels can be wrong.
Explore by health goal
Editorial transparency
- Written by
- AlternativeMed editorial team. Research compiled with AI assistance, then checked against the sources listed.
- Medical review
- None. This page has not been reviewed by a physician or pharmacist.
- First published
- 2026-10-26
- Last substantive update
- 2026-10-26
- How we research
- We started from our existing summary, re-opened every source on it, read NIDDK and NHS pages, and re-read PubMed abstracts for reviews and trials. Only abstracts were read for studies.
- How we rate evidence
- See "How we rate evidence" in the Evidence tab.
- Independence
- No product is promoted on this page. No affiliate links are shown. Several trials were funded by or linked to the product makers; this is stated where known.
Sources 19
Each source was opened and checked. Where we read only the abstract, it says so. The small numbers in the text point here.
- Benetti F, Petrini E, Sordi R, Gaio E, Biagi M. A Multidisciplinary Analytical Strategy for the Authentication and Quality Assessment of Bromelain in Dietary Supplements.. Int J Mol Sci. 2026. PMID 42123415. DOI 10.3390/ijms27093830. (abstract)
- Edakkanambeth Varayil J, Bauer BA, Hurt RT. Over-the-counter enzyme supplements: what a clinician needs to know.. Mayo Clin Proc. 2014. PMID 25103998. DOI 10.1016/j.mayocp.2014.05.015. (abstract)
- Ganiats TG, Norcross WA, Halverson AL, Burford PA, Palinkas LA. Does Beano prevent gas? A double-blind crossover study of oral alpha-galactosidase to treat dietary oligosaccharide intolerance.. J Fam Pract. 1994. PMID 7964541. (abstract)
- Hillila M, Farkkila MA, Sipponen T, Rajala J, Koskenpato J. Does oral alpha-galactosidase relieve irritable bowel symptoms?. Scand J Gastroenterol. 2016. PMID 26133538. DOI 10.3109/00365521.2015.1063156. (abstract)
- Ianiro G, Pecere S, Giorgio V, Gasbarrini A, Cammarota G. Digestive Enzyme Supplementation in Gastrointestinal Diseases.. Curr Drug Metab. 2016. PMID 26806042. DOI 10.2174/138920021702160114150137. (abstract)
- Kaye AJ, Meyers SR, Hachuel D, Wells J, Wallach T, Thor S. FODMAP-Targeting Digestive Enzyme Blend for Management of Gastrointestinal Symptoms: A "Real-World" Pre-Post Intervention Cohort Study.. Gastro Hep Adv. 2026. PMID 41908325. DOI 10.1016/j.gastha.2026.100898. (abstract)
- Kozlowska-Jalowska A, Strozyk A, Horvath A, Szajewska H. Effect of lactase supplementation on infant colic: Systematic review of randomized controlled trials.. J Pediatr Gastroenterol Nutr. 2024. PMID 38426798. DOI 10.1002/jpn3.12144. (abstract)
- Levine ME, Koch SY, Koch KL. Lipase Supplementation before a High-Fat Meal Reduces Perceptions of Fullness in Healthy Subjects.. Gut Liver. 2015. PMID 25287168. DOI 10.5009/gnl14005. (abstract)
- Mah E, McKenna CF, Blonquist TM, Kaden VN, Shah AM, Qu Y et al.. Oral Fructanase Administration Reduces Gastrointestinal Symptom Severity after Acute Inulin Challenge in Healthy Adults.. J Nutr. 2026. PMID 42580594. DOI 10.1016/j.tjnut.2026.101782. (abstract)
- Majeed M, Majeed S, Nagabhushanam K, Arumugam S, Pande A, Paschapur M et al.. Evaluation of the Safety and Efficacy of a Multienzyme Complex in Patients with Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study.. J Med Food. 2018. PMID 30156436. DOI 10.1089/jmf.2017.4172. (abstract)
- Shaukat A, Levitt MD, Taylor BC, MacDonald R, Shamliyan TA, Kane RL, Wilt TJ. Systematic review: effective management strategies for lactose intolerance.. Ann Intern Med. 2010. PMID 20404262. DOI 10.7326/0003-4819-152-12-201006150-00241. (abstract)
- Ullah H, Di Minno A, Piccinocchi R, Buccato DG, De Lellis LF, Baldi A et al.. Efficacy of digestive enzyme supplementation in functional dyspepsia: A monocentric, randomized, double-blind, placebo-controlled, clinical trial.. Biomed Pharmacother. 2023. PMID 37976892. DOI 10.1016/j.biopha.2023.115858. (abstract)
- Whitcomb DC, Buchner AM, Forsmark CE. AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert Review.. Gastroenterology. 2023. PMID 37737818. DOI 10.1053/j.gastro.2023.07.007. (abstract)
- . NHS: Bloating (page last reviewed 21 January 2026). . . (full-text)
- . NHS: Lactose intolerance (page last reviewed 8 July 2026). . . (full-text)
- . NIDDK: Symptoms & Causes for Exocrine Pancreatic Insufficiency (last reviewed January 2023). . . (full-text)
- . NIDDK: Treatment for Exocrine Pancreatic Insufficiency (last reviewed January 2023). . . (full-text)
- . NIDDK: Treatment for Gas in the Digestive Tract (last reviewed June 2021). . . (full-text)
- . NIDDK: Treatment for Lactose Intolerance (last reviewed February 2018). . . (full-text)
Where to buy
Check the label first. Whatever you buy, look for these:
- The amount of the active ingredient per serving, not just the front-label claim
- A third-party testing mark (USP, NSF or ConsumerLab)
- Other ingredients and allergens
- Ask a pharmacist about interactions with your medicines
Talk to a pharmacist or doctor before you start any supplement, especially if you take medicines. See the Safety tab for interactions.
Support our free guides: as an Amazon Associate we earn from qualifying purchases. Full disclosure.